Plano TX 心血管疾病临床试验
10项针对 心血管疾病的研究正在 Plano及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
招募中
- The Heart Hospital Baylor Plano, Plano
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
招募中3 期
- Clinical Trial Site, Plano
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
招募中
- The Heart Hospital Baylor Plano, Plano
ELEVATE-HFpEF Clinical Study
招募中
- Baylor Research Institute, Plano
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
招募中
- The Heart Hospital Baylor Plano, Plano
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
招募中3 期
- Research Site, Plano
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
招募中3 期
- Valley Institute of Research Plano, Plano
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
招募中
- Baylor Scott & White The Heart Hospital - Plano, Plano
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
招募中
- Baylor Scott & White - The Heart Hospital - Plano, Plano
其他城市的 心血管疾病试验
- Boston, MA34 项研究
- New York City, NY30 项研究
- Washington, DC27 项研究
- Dallas, TX24 项研究
- Houston, TX22 项研究
- Philadelphia, PA22 项研究
- Pittsburgh, PA21 项研究
- St. Louis, MO20 项研究
- Cleveland, OH20 项研究
- San Francisco, CA20 项研究
- Chicago, IL20 项研究
- Atlanta, GA20 项研究
Plano的其他研究
- 心力衰竭13 项研究
- 冠状动脉疾病9 项研究
- 主动脉瓣狭窄5 项研究
- 非小细胞肺癌4 项研究
- 肥胖症4 项研究
- 心脏病4 项研究
- 抑郁症4 项研究
- 精神分裂症3 项研究
- 三尖瓣关闭不全3 项研究
- 肥厚型心肌病3 项研究
- 心绞痛3 项研究
- 主动脉夹层3 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年11月15日。每项研究自行设定入选标准,由研究团队决定谁能参与。